BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kang C, Jeong SY, Song SY, Choi EK. The emerging role of myeloid-derived suppressor cells in radiotherapy. Radiat Oncol J 2020;38:1-10. [PMID: 32229803 DOI: 10.3857/roj.2019.00640] [Cited by in Crossref: 14] [Cited by in F6Publishing: 18] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Jou E, Rodriguez-Rodriguez N, Ferreira AF, Jolin HE, Clark PA, Sawmynaden K, Ko M, Murphy JE, Mannion J, Ward C, Matthews DJ, Buczacki SJA, McKenzie ANJ. An innate IL-25-ILC2-MDSC axis creates a cancer-permissive microenvironment for Apc mutation-driven intestinal tumorigenesis. Sci Immunol 2022;7:eabn0175. [PMID: 35658010 DOI: 10.1126/sciimmunol.abn0175] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
2 Mudassar F, Shen H, Cook KM, Hau E. Improving the synergistic combination of programmed death‐1/programmed death ligand‐1 blockade and radiotherapy by targeting the hypoxic tumour microenvironment. J Med Imag Rad Onc. [DOI: 10.1111/1754-9485.13416] [Reference Citation Analysis]
3 Kim Y, Choi C, Park JH, Ahn W, Shin S, Kim S, Noh JM. Immunomodulatory effect of splenectomy in lung cancer mouse xenograft models receiving radiation therapy. Radiat Oncol J 2022;40:53-65. [DOI: 10.3857/roj.2021.00885] [Reference Citation Analysis]
4 Weadick CS, Duffy AG, Kelly RJ. Recent advances in immune-based approaches for the treatment of esophagogastric cancer. Expert Opin Emerg Drugs 2022;:1-13. [PMID: 34937483 DOI: 10.1080/14728214.2021.2020757] [Reference Citation Analysis]
5 Kalyanaraman B. Reactive oxygen species, proinflammatory and immunosuppressive mediators induced in COVID-19: overlapping biology with cancer. RSC Chem Biol 2021;2:1402-14. [PMID: 34704045 DOI: 10.1039/d1cb00042j] [Reference Citation Analysis]
6 Choi YY, Seong KM, Lee HJ, Lee SS, Kim A. Expansion of monocytic myeloid-derived suppressor cells ameliorated intestinal inflammatory response by radiation through SOCS3 expression. Cell Death Dis 2021;12:826. [PMID: 34480017 DOI: 10.1038/s41419-021-04103-x] [Reference Citation Analysis]
7 Vito A, Rathmann S, Mercanti N, El-Sayes N, Mossman K, Valliant J. Combined Radionuclide Therapy and Immunotherapy for Treatment of Triple Negative Breast Cancer. Int J Mol Sci 2021;22:4843. [PMID: 34063642 DOI: 10.3390/ijms22094843] [Reference Citation Analysis]
8 Reijmen E, De Mey S, De Mey W, Gevaert T, De Ridder K, Locy H, Martens S, De Blay E, Bouwens L, Debie P, Breckpot K, De Grève J, De Ridder M, Goyvaerts C. Fractionated Radiation Severely Reduces the Number of CD8+ T Cells and Mature Antigen Presenting Cells Within Lung Tumors. Int J Radiat Oncol Biol Phys 2021;111:272-83. [PMID: 33865948 DOI: 10.1016/j.ijrobp.2021.04.009] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Goff PH, Zeng J, Rengan R, Schaub SK. Radiation and Modulation of the Tumor Immune Microenvironment in Non-Small Cell Lung Cancer. Semin Radiat Oncol 2021;31:133-9. [PMID: 33610270 DOI: 10.1016/j.semradonc.2020.11.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Mandula JK, Rodriguez PC. Tumor-related stress regulates functional plasticity of MDSCs. Cell Immunol 2021;363:104312. [PMID: 33652258 DOI: 10.1016/j.cellimm.2021.104312] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Jeong BK, Kim JH, Jung MH, Kang KM, Lee YH. Cytokine Profiles of Non-Small Cell Lung Cancer Patients Treated with Concurrent Chemoradiotherapy with Regards to Radiation Pneumonitis Severity. J Clin Med 2021;10:699. [PMID: 33670117 DOI: 10.3390/jcm10040699] [Reference Citation Analysis]
12 Kho VM, Mekers VE, Span PN, Bussink J, Adema GJ. Radiotherapy and cGAS/STING signaling: Impact on MDSCs in the tumor microenvironment. Cell Immunol 2021;362:104298. [PMID: 33592541 DOI: 10.1016/j.cellimm.2021.104298] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
13 Yu JI, Park HC, Yoo GS, Choi C, Choi MS, Nam H, Baek SY, Park M. Clinical importance of the absolute count of neutrophils, lymphocytes, monocytes, and platelets in newly diagnosed hepatocellular carcinoma. Sci Rep 2021;11:2614. [PMID: 33510378 DOI: 10.1038/s41598-021-82177-5] [Reference Citation Analysis]
14 MacDonald C, Ministero S, Pandey M, Robinson D, Forti Hong E, Hylander B, McCarthy P, Gordon C, Repasky E, Mohammadpour H. Comparing thermal stress reduction strategies that influence MDSC accumulation in tumor bearing mice. Cell Immunol 2021;361:104285. [PMID: 33484943 DOI: 10.1016/j.cellimm.2021.104285] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
15 Kim N, Yu JI, Park HC, Yoo GS, Choi C, Hong JY, Lim HY, Lee J, Choi MS, Lee JE, Kim K. Incorporating sarcopenia and inflammation with radiation therapy in patients with hepatocellular carcinoma treated with nivolumab. Cancer Immunol Immunother 2021;70:1593-603. [PMID: 33231725 DOI: 10.1007/s00262-020-02794-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
16 Jo Y, Ali LA, Shim JA, Lee BH, Hong C. Innovative CAR-T Cell Therapy for Solid Tumor; Current Duel between CAR-T Spear and Tumor Shield. Cancers (Basel) 2020;12:E2087. [PMID: 32731404 DOI: 10.3390/cancers12082087] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Ashrafizadeh M, Farhood B, Eleojo Musa A, Taeb S, Najafi M. The interactions and communications in tumor resistance to radiotherapy: Therapy perspectives. Int Immunopharmacol 2020;87:106807. [PMID: 32683299 DOI: 10.1016/j.intimp.2020.106807] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
18 Yu JI, Park HC, Yoo GS, Paik SW, Choi MS, Kim HS, Sohn I, Nam H. Clinical Significance of Systemic Inflammation Markers in Newly Diagnosed, Previously Untreated Hepatocellular Carcinoma. Cancers (Basel) 2020;12:E1300. [PMID: 32455607 DOI: 10.3390/cancers12051300] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]